GlassScriptPhysician profile
Michael Hutchinson
NPI 1720169543
$2,784.77
in general payments reported to CMS, 2019-2025
10 companies · $551 in 2025
The $551 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.81 · 2020: $31.86 · 2021: $79.60 · 2022: $639 · 2023: $627 · 2024: $813 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,966 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,965.88 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $1,255.55 | 2022-2025 | Gocovri, Gocovri |
| Abbvie INC. | $1,030.18 | 2021-2025 | |
| Allergan, INC. | $272.59 | 2019-2022 | |
| Celgene Corporation | $43.75 | 2022 | |
| Bausch Health US, LLC | $40.67 | 2023 | Aplenzin, Wellbutrin |
| Biohaven Pharmaceutical Holding Company LTD. | $39.26 | 2022 | |
| Lundbeck LLC | $37.13 | 2023-2025 | Rexulti, Vyepti |
| Emd Serono, INC. | $33.42 | 2023 | Mavenclad |
| Boston Scientific Corporation | $16.25 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hutchinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.